W. Urassa et al., The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania, J CLIN VIRO, 14(1), 1999, pp. 25-29
Background: Constant improvement of HIV tests often results in withdrawal o
f poorer quality tests by the manufacturing companies. It is thus often nec
essary to evaluate new HIV testing kits and modify the existing testing str
ategies.
Objectives: To evaluate an alternative HIV antibody testing strategy which
involves consecutive testing of sera by two enzyme-linked immunosorbent ass
ays (ELISA), which both are recombinant antigen-based but utilise different
test principles, followed by re-testing of sera giving discordant results.
Study design: Sera (n = 1558) from a cross-sectional study of the HIV-I ser
oprevalence in the Kagera region of Tanzania were tested using two ELISAs i
n parallel: Enzygnost anti-HIV-1/2 plus and Wellcozyme HIV-1 recombinant. W
estern blot analysis was done on all concordantly reactive and repeatedly d
iscordant reactive samples as well as on 10% of concordantly ELISA negative
sera.
Results: Two hundred and four sera (13.1%) were confirmed HIV-l-antibody po
sitive. Both ELISAs had a sensitivity of 100%. The specificities of the ELI
SAs at initial and repeated testing were 99.8 and 99.9%, respectively, for
Enzygnost and 97.7 and 99.5%, respectively, for Wellcozyme. None of the ser
a was concordantly false positive in both ELISAs. The mean ratio of the opt
ical density of a sample to the cut off value of the test run (OD/CO ratio)
was lower for samples giving false positive reactions than for confirmed H
IV-l-antibody-positive samples. It is therefore important to interpret with
caution HIV antibody ELISA test results on samples giving low OD/CO ratios
. None of 10% of randomly selected concordantly ELISA negative sera gave a
positive Western blot reaction.
Conclusions: This field evaluation of an HIV antibody testing strategy invo
lving the use of a recombinant antigen-based sandwich ELISA (Enzygnost) fol
lowed by a recombinant antigen-based competitive ELISA (Well cozyme) showed
that it had a sensitivity and specificity of 100%. (C) 1999 Elsevier Scien
ce B.V. All rights reserved.